TTrialPathMatch Me to Trials
← Back to trials
RecruitingHepatitis CPregnancy Complications

Feasibility and Acceptability of HCV Treatment in Pregnancy

Eligible age

18+ yrs

Accepts

Women

Locations

1 state

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

Pregnant adults over the age of 18 who are seen in the Washington University obstetrics and gynecology, maternal fetal medicine or infectious diseases clinic or admitted to BJH with hepatitis C virus infection who have a history of past or current drug use Participant Duration: Approximately 1 year. Aims: Aim 1 - Evaluate adherence and treatment completion rates when glecaprevir-pibrentasvir is started during pregnancy for women who use drugs. Aim 2 - Evaluate patient experience with hepatitis C virus treatment during pregnancy.

Sponsor: Washington University School of Medicine

You may qualify if…

  • ✓ Female patients ≥ 18 years old, pregnant at the time of study intake, diagnosed with hepatitis c virus infection and a history of past or current drug use.

You may not qualify if…

  • ✕ \-

Where it's recruiting

Missouri

St Louis

Source: ClinicalTrials.gov · NCT06367465 · last updated 2026-06-09